Academic
Publications
Effect of Coenzyme Q 10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial

Effect of Coenzyme Q 10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial,10.1016/j.neurobiolag

Effect of Coenzyme Q 10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial   (Citations: 1)
BibTex | RIS | RefWorks Download
Down syndrome (DS) is a chromosomal abnormality (trisomy 21) associated with a complex phenotype. Oxidative stress is known to play a major role in this pathology both due to genetic and epigenetic factors, suggesting that oxidative imbalance contributes to the clinical manifestation of DS. In particular, the implications of oxidative DNA damage in Down syndrome has been linked with neurodegeneration. Here we report the results of a double blind controlled trial aimed at investigating the protective effect of Coenzyme Q10 on DNA oxidation in this clinical setting using the single cell gel electrophoresis technique.
Journal: Neurobiology of Aging - NEUROBIOL AGING , vol. 32, no. 11, pp. 2103-2105, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: